Manufacturing GSK to quit Stevenage for new R&D site in Cambridge PharmaphorumIn a major shake-up of its UK operations, GSK is building a brand new R D centre in Cambridge and transfer operations there from its Stevenage campus.Read full story pharminent July 28, 2026 (Last updated: July 30, 2026) Pharmaphorum In a major shake-up of its UK operations, GSK is building a brand new R D centre in Cambridge and transfer operations there from its Stevenage campus. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Argenx signs agreement to buy Forte Biosciences for $2.2bnNext: Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study Related Stories Manufacturing GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy pharminent July 29, 2026 Manufacturing Trump Threatens 100%–200% Tariffs on Imported Generic Drugs pharminent July 22, 2026 Manufacturing Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing pharminent July 22, 2026
